MLchartDataset catalogue

di-dgA-RFB4

Term · Oncology and biomedicine · MLC-T-ONC-002432

An anticancer drug that is a combination of a monoclonal antibody (RFB4) and an immunotoxin (dgA).

Table 1. Record
IdentifierMLC-T-ONC-002432
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-002432",
  "term": "di-dgA-RFB4",
  "field": "Oncology and biomedicine",
  "definition": "An anticancer drug that is a combination of a monoclonal antibody (RFB4) and an immunotoxin (dgA).",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/di-dga-rfb4/"
}

Record 5,967 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.